Quick Details
● ProName: Manufacturer supply bupivacaine
● CasNo: 2180-92-9
● Molecular Formula: C18H28N2O
● Appearance: White Crystalline Powder
● Application: local anesthetic
● DeliveryTime: Within three or five working days
● PackAge: 1kg/bag,seald package or at customer r...
● Port: China main port
● ProductionCapacity: 10 Metric Ton/Month
● Purity: 99.9%
● Storage: Sealed container
● Transportation: Sealed container at cool&dry place
● LimitNum: 1 Kilogram
● Heavy Metal: Not detected
● Valid Period: 2020-12-15
Superiority
1.advanced factory building and equipment
2.competent technical team
3.strong r & d support
4.high quality products with high stability
5.competitive price
6.customer tailored service
product description:
bupivacaine
synonyms:marcaine;bupivacaine;bupivacaine base;(.+/-.)-1-butyl-2',6'-pipecoloxylidide;1-butyl-2-(2,6-xylycarbamoyl)piperidine;1-butyl-2',6'-pipecoloxylidide;1-butyl-2',6'-pipecoloxylidide;1-butyl-n-(2,6-dimethylphenyl)-2-piperidinecarboxamid
cas:2180-92-9
mf:c18h28n2o
mw:288.43
bupivacaine is indicated for local anesthesia including infiltration, nerve block, epidural, and intrathecal anesthesia. bupivacaine often is administered by epidural injection before total hip arthroplasty. it also is commonly injected to surgical wound sites to reduce pain for up to 20 hours after the surgery. sometimes, bupivacaine is co-administered withepinephrine to prolong the duration of its action, fentanyl for epidural analgesia, or glucose.
bupivacaine is contraindicated for intravenous regional anaesthesia (ivra) because of potential risk of tourniquet failure and systemic absorption of the drug.
levobupivacaine is the (s)-(–)-enantiomer of bupivacaine, with a longer duration of action and produces less vasodilation. durect corporation is developing a biodegradable controlled-release drug delivery system for post surgery. it has currently completed a phase iii clinical trial.
tests | specifications |
description | white crystalline powder. |
solubility | freely soluble in water and in alcohol; slightly soluble in chloroform and in acetone. |
identification | a: by ir, to match with working standard |
b: by uv, to match with working standard | |
c: chloride test, to matching with the standard | |
ph | 4.5 ~ 6.0 |
water | 4.0%~6.0% |
residue on ignition | ≤ 0.1% |
heavy metals | ≤ 0.001% |
limit of residual solvents | should be to match with the standard |
chromatographic purity | should be to match with the standard |
assay | 98.5~101.5% (on the anhydrous basis.) |
other topical pain relief powders:
| benzocaine | cas:94-09-7 |
benzocaine hydrochloride | cas:23239-88-5 |
tetracaine hydrochloride | cas:136-47-0 |
procaine | cas:59-46-1 |
tetracaine | cas:94-24-6 |
pramoxine hydrochloride | cas:637-58-1 |
procaine hcl | cas:51-05-8 |
lidocaine | cas:137-58-6 |
dibucaine hydrochloride | cas:61-12-1 |
prilocaine | cas:721-50-6 |
propitocaine hydrochloride | cas:1786-81-8 |
proparacaine hydrochloride | cas:5875-06-9 |
lidocaine hydrochloride | cas:73-78-9 |
articaine hydrochloride | cas:23964-57-0 |
levobupivacaine hydrochloride | cas:27262-48-2 |
ropivacaine hydrochloride | cas:132112-35-7 |
bupivacaine | cas:2180-92-9 |
bupivacaine hydrochloride | cas:14252-80-3 |
Product: | Bupivacaine (base) |
Cas No.: | 2180-92-9 |
Molecular Formula: | C18H28N2O |
Structure: |
|
Related products |
Metronidazole |
